WO2008051889Pellets containing an analgesic uniformly dispersed in a lipid carrier such as cholesterol mixed with fatty acid esters, can be used to provide long term pain relief. 5 mg cholesterol-tryglyceride- buprenorphine pellets released the majority of drug in 24-48 hours after implant and provide clinically significant plasma levels of analgesia in mice for 3-9 days. Blood levels of analgesia peak at day-1 and are substantially complete by day-5 depending on the level of buprenorphine. These results demonstrate that post surgical implants provide clinically significant levels of analgesia in the 24-48 hour period following surgery and thus obviate the time consuming, expensive, and high-risk need to inject mice post surgery. The pellets are safe and simple to use. Placed in the surgical wound at the end of surgery, they provide 2-3 days of analgesia and obviate the need for subsequent handling of the animal for pain therapy. The implants have no detectable effect on mouse behavior, hematology, or liver chemistry. The unexpected release kinetics of the 5 mg pellet provides an ideal implant for post surgical analgesia. These implants solve a significant problem facing scientists who use rodents in research and abide by international of animal welfare. US2008058689A phototherapy bandage capable of providing radiation to a localized area of a patient for accelerating would healing and pain relief, photodynamic therapy, and for aesthetic applications. The phototherapy bandage may include a flexible light source that is continuous across the bandage for providing a selected light, such as a visible light, a near-infrared light, or other light, having substantially similar intensity across the bandage. The bandage may also be flexible and capable of being attached to a patient without interfering with the patient’s daily routine. The phototherapy bandage may easily conform to the curves of a patient and may come in a variety of exterior shapes and sizes. WO2008021404A composition providing cobalamine, cobalamine subtype or cobalamine analog as an effective agent for topical or transdermal administration to alleviate pain associated with a generalized or focal peripheral neuropathic condition, such as carpal tunnel syndrome. Pain relief compositions for use in complementary therapy are also provided. US2007276457An infrared heating device and therapy for lower back pain includes a belt fastenable around a user so that the belt is overlaying at least a part of a lumbar region of the user. An infrared emitting element is adjustably positionable between the belt and at a selected area of the user’s lumbar region where a user desires pain relief therapy. A portable power supply is attachable to the belt and electrically connectable to the infrared emitting element so that the user can receive infrared therapy at specific selected areas of the lower back while moving, standing, sitting, reclining or sleeping. US2007255187A device for providing therapy to a user including vibration and temperature modulation. The device provides mobile temperature modulation capabilities, mobile vibration capabilities, or a combination of the two. The device provides advantages to a person or animal including the ability to utilize the device in a hands-free manner. The device may also provide, under certain circumstances, pain relief or healing therapy to a person or animal.